Review Article: is Helicobacter pylori relevant in the management of reflux disease? (Q34327956)

1 August 2017

1 reference

title

Review Article: is Helicobacter pylori relevant in the management of reflux disease? (English)

1 reference

Helicobacter pylori infectious disease

1 August 2017

0 references

1 reference

Dent J

1

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

Alimentary Pharmacology & Therapeutics

1 August 2017

published in

1 reference

1 August 2017

volume

15 Suppl 1

1 reference

1 August 2017

page(s)

16-21

1 reference

Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

Helicobacter pylori infection and chronic gastric acid hyposecretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

The effect of Helicobacter pylori eradication on gastro-oesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

Efficacy of combination therapy of interferon-alpha with ursodeoxycholic acid in chronic hepatitis C: a randomized controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00103.X

10.1046/J.1365-2036.2001.00103.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference